Neogen Price to Sales Ratio 2010-2025 | NEOG
Historical PS ratio values for Neogen (NEOG) over the last 10 years. The current P/S ratio for Neogen as of May 06, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Neogen P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-06 | 5.49 | 1.31 | |
| 2025-02-28 | 10.05 | $4.18 | 2.40 |
| 2024-11-30 | 14.18 | $4.22 | 3.36 |
| 2024-08-31 | 17.25 | $4.21 | 4.09 |
| 2024-05-31 | 13.15 | $4.27 | 3.08 |
| 2024-02-29 | 17.19 | $4.45 | 3.86 |
| 2023-11-30 | 16.97 | $4.41 | 3.85 |
| 2023-08-31 | 23.12 | $4.41 | 5.24 |
| 2023-05-31 | 17.49 | $4.58 | 3.82 |
| 2023-02-28 | 17.69 | $4.60 | 3.85 |
| 2022-11-30 | 16.56 | $4.77 | 3.47 |
| 2022-08-31 | 20.90 | $4.92 | 4.25 |
| 2022-05-31 | 26.46 | $4.88 | 5.43 |
| 2022-02-28 | 35.70 | $4.77 | 7.49 |
| 2021-11-30 | 40.13 | $4.67 | 8.59 |
| 2021-08-31 | 43.78 | $4.54 | 9.64 |
| 2021-05-31 | 46.16 | $4.38 | 10.54 |
| 2021-02-28 | 40.96 | $4.22 | 9.70 |
| 2020-11-30 | 37.11 | $4.08 | 9.11 |
| 2020-08-31 | 38.10 | $4.02 | 9.48 |
| 2020-05-31 | 35.61 | $3.95 | 9.00 |
| 2020-02-29 | 30.38 | $3.97 | 7.65 |
| 2019-11-30 | 33.29 | $3.96 | 8.41 |
| 2019-08-31 | 35.26 | $3.96 | 8.91 |
| 2019-05-31 | 28.18 | $3.94 | 7.15 |
| 2019-02-28 | 30.98 | $3.93 | 7.88 |
| 2018-11-30 | 32.43 | $3.91 | 8.30 |
| 2018-08-31 | 46.72 | $3.86 | 12.11 |
| 2018-05-31 | 37.86 | $3.83 | 9.89 |
| 2018-02-28 | 29.14 | $3.72 | 7.82 |
| 2017-11-30 | 31.46 | $3.68 | 8.56 |
| 2017-08-31 | 25.84 | $3.60 | 7.18 |
| 2017-05-31 | 23.73 | $3.50 | 6.77 |
| 2017-02-28 | 24.32 | $3.46 | 7.02 |
| 2016-11-30 | 23.73 | $3.36 | 7.06 |
| 2016-08-31 | 22.15 | $3.26 | 6.79 |
| 2016-05-31 | 18.51 | $3.18 | 5.82 |
| 2016-02-29 | 18.47 | $3.08 | 6.00 |
| 2015-11-30 | 22.15 | $3.00 | 7.38 |
| 2015-08-31 | 19.36 | $2.90 | 6.67 |
| 2015-05-31 | 17.53 | $2.84 | 6.18 |
| 2015-02-28 | 19.18 | $2.73 | 7.03 |
| 2014-11-30 | 16.62 | $2.67 | 6.23 |
| 2014-08-31 | 15.79 | $2.58 | 6.12 |
| 2014-05-31 | 14.17 | $2.49 | 5.69 |
| 2014-02-28 | 16.24 | $2.39 | 6.79 |
| 2013-11-30 | 19.08 | $2.29 | 8.33 |
| 2013-08-31 | 13.52 | $2.21 | 6.11 |
| 2013-05-31 | 13.62 | $2.14 | 6.38 |
| 2013-02-28 | 11.70 | $2.06 | 5.67 |
| 2012-11-30 | 11.39 | $2.01 | 5.67 |
| 2012-08-31 | 9.76 | $1.96 | 4.99 |
| 2012-05-31 | 9.73 | $1.92 | 5.08 |
| 2012-02-29 | 8.67 | $1.87 | 4.64 |
| 2011-11-30 | 8.81 | $1.84 | 4.78 |
| 2011-08-31 | 8.68 | $1.84 | 4.73 |
| 2011-05-31 | 11.21 | $1.82 | 6.16 |
| 2011-02-28 | 9.35 | $1.78 | 5.24 |
| 2010-11-30 | 9.29 | $1.71 | 5.44 |
| 2010-08-31 | 7.30 | $1.63 | 4.49 |
| 2010-05-31 | 6.43 | $1.52 | 4.22 |
| 2010-02-28 | 6.06 | $1.44 | 4.20 |
| 2009-11-30 | 5.42 | $1.38 | 3.92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.224B | $0.924B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.702B | 27.74 |
| Boston Scientific (BSX) | United States | $154.217B | 38.61 |
| Stryker (SYK) | United States | $145.561B | 30.44 |
| EssilorLuxottica (ESLOY) | France | $133.244B | 0.00 |
| Medtronic (MDT) | Ireland | $107.028B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.631B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.943B | 27.26 |
| ResMed (RMD) | United States | $35.287B | 26.50 |
| GE HealthCare Technologies (GEHC) | United States | $31.763B | 15.08 |
| Agilent Technologies (A) | United States | $30.897B | 20.41 |
| Terumo (TRUMY) | Japan | $29.152B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.100B | 17.21 |
| Insulet (PODD) | United States | $18.209B | 77.71 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.901B | 11.50 |
| Baxter (BAX) | United States | $15.608B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.425B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.395B | 18.18 |
| Bio-Rad Laboratories (BIO) | United States | $6.728B | 22.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.111B | 19.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.444B | 9.86 |
| ICU Medical (ICUI) | United States | $3.347B | 28.51 |
| Haemonetics (HAE) | United States | $3.139B | 14.77 |
| Envista Holdings (NVST) | United States | $2.876B | 23.90 |
| GN Store Nord (GNNDY) | Denmark | $2.071B | 17.15 |
| QuidelOrtho (QDEL) | United States | $1.868B | 15.64 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.63 |
| AtriCure (ATRC) | United States | $1.439B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.359B | 21.40 |
| AdaptHealth (AHCO) | United States | $1.173B | 11.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.150B | 0.00 |
| InMode (INMD) | Israel | $0.991B | 9.08 |
| Phibro Animal Health (PAHC) | United States | $0.791B | 12.13 |
| Evolus (EOLS) | United States | $0.774B | 0.00 |
| Owens & Minor (OMI) | United States | $0.632B | 5.38 |
| Curaleaf Holdings (CURLF) | Canada | $0.618B | 0.00 |
| CeriBell (CBLL) | United States | $0.583B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.470B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.442B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.437B | 0.00 |
| Omeros (OMER) | United States | $0.397B | 0.00 |
| Surmodics (SRDX) | United States | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.348B | 15.09 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.312B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 26.18 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.265B | 47.20 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 14.80 |
| Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.178B | 4.06 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.91 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.118B | 0.00 |
| Exagen (XGN) | United States | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.61 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 59.50 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.31 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |